Jintong Chen

408 total citations
20 papers, 314 citations indexed

About

Jintong Chen is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Jintong Chen has authored 20 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Jintong Chen's work include Immune Cell Function and Interaction (7 papers), IL-33, ST2, and ILC Pathways (6 papers) and Immunotherapy and Immune Responses (6 papers). Jintong Chen is often cited by papers focused on Immune Cell Function and Interaction (7 papers), IL-33, ST2, and ILC Pathways (6 papers) and Immunotherapy and Immune Responses (6 papers). Jintong Chen collaborates with scholars based in China and United States. Jintong Chen's co-authors include Siqing Wang, Yinghua Zhao, Qing Yi, Yuxue Jiang, Xiao Chu, Sujun Gao, Huanfa Yi, Xiaoqing Zhu, Yiming Wang and Yong Lu and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Jintong Chen

16 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jintong Chen China	9	198	80	77	42	28	20	314
Cindy Audiger Canada	8	219 1.1×	102 1.3×	45 0.6×	22 0.5×	28 1.0×	16	348
Kristina Scheibe Germany	5	120 0.6×	71 0.9×	57 0.7×	26 0.6×	15 0.5×	6	242
Hanxi Xiao United States	10	167 0.8×	109 1.4×	82 1.1×	19 0.5×	47 1.7×	19	309
Keigo Kubota Japan	6	196 1.0×	106 1.3×	121 1.6×	22 0.5×	50 1.8×	7	328
Naveen Sharma India	9	188 0.9×	82 1.0×	109 1.4×	29 0.7×	33 1.2×	27	330
Aijie Liu United States	10	224 1.1×	112 1.4×	103 1.3×	19 0.5×	29 1.0×	19	351
Achia Khatun United States	13	285 1.4×	105 1.3×	108 1.4×	55 1.3×	16 0.6×	17	403
Kebria Hezaveh Canada	8	215 1.1×	111 1.4×	105 1.4×	13 0.3×	33 1.2×	11	337
Francesco Siracusa Germany	9	229 1.2×	87 1.1×	58 0.8×	22 0.5×	19 0.7×	12	355

Countries citing papers authored by Jintong Chen

Since Specialization

Citations

This map shows the geographic impact of Jintong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jintong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jintong Chen more than expected).

Fields of papers citing papers by Jintong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jintong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jintong Chen. The network helps show where Jintong Chen may publish in the future.

Co-authorship network of co-authors of Jintong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jintong Chen. A scholar is included among the top collaborators of Jintong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jintong Chen. Jintong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Ling‐Li, et al.. (2024). Adropin regulates macrophage phenotype via PPARγ signalling: A preliminary study of adropin and Crohn's disease. Scandinavian Journal of Immunology. 100(6). e13415–e13415.

Chen, Jintong, et al.. (2024). Palmitic acid inhibits macrophage-mediated chemotherapy resistance in multiple myeloma via ALOX12 signaling. International Immunopharmacology. 143(Pt 1). 113320–113320.

Chen, Jintong, et al.. (2023). Diarrhea After Gastric Surgery: More Than Meets the Eye. Clinical Gastroenterology and Hepatology. 22(4). A25–A26.

Chen, Jintong, et al.. (2023). Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score‐matched analysis of US nationwide inpatient sample 2016–2018. Journal of Digestive Diseases. 24(11). 572–583. 3 indexed citations

Chen, Jintong, et al.. (2023). IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy. iScience. 26(9). 107531–107531. 9 indexed citations

Zhang, Mingyue, et al.. (2023). Interleukin-10 increases macrophage-mediated chemotherapy resistance via FABP5 signaling in multiple myeloma. International Immunopharmacology. 124(Pt A). 110859–110859. 5 indexed citations

Chen, Jintong, et al.. (2023). Clinical characteristics and quality of life in patients with inflammatory bowel disease-associated anemia in Southeast China. European Journal of Gastroenterology & Hepatology. 35(3). 275–284.

Chen, Jintong, et al.. (2023). Serum food specific IgG antibodies are associated with small bowel inflammation in patients with Crohn’s disease. European Journal of Clinical Nutrition. 78(1). 48–53. 2 indexed citations

Zhang, Hua, Jintong Chen, Mingyue Zhang, et al.. (2022). Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma. Medical Oncology. 39(5). 55–55. 8 indexed citations

10.

Liu, Ning, Jintong Chen, Yinghua Zhao, et al.. (2021). Role of the IL‑33/ST2 receptor axis in ovarian cancer progression (Review). Oncology Letters. 22(1). 504–504. 4 indexed citations

11.

Chen, Jintong, et al.. (2021). Association between ABO blood group and risk of Crohn’s disease: A case‐control study in the Chinese Han population. Journal of Clinical Laboratory Analysis. 36(2). e24195–e24195. 4 indexed citations

12.

Ding, Jian, Li Qiu, Jiewen Lin, et al.. (2020). Optical coherence tomography for the early detection of colorectal dysplasia and cancer: validation in a murine model. Quantitative Imaging in Medicine and Surgery. 11(1). 371–379. 11 indexed citations

13.

Yang, Siyu, Jintong Chen, Hong Zhang, et al.. (2020). TNF-a Is a Potent Stimulator of Tc9-Cell Differentiation. Journal of Immunotherapy. 43(9). 265–272. 7 indexed citations

14.

Jiang, Yuxue, Jintong Chen, Enguang Bi, et al.. (2019). TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways. Journal for ImmunoTherapy of Cancer. 7(1). 28–28. 48 indexed citations

15.

Liu, Ning, Yuxue Jiang, Jintong Chen, et al.. (2018). IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells. Cellular and Molecular Immunology. 16(7). 644–651. 28 indexed citations

16.

Wang, Dongjiao, Sujun Gao, Jintong Chen, et al.. (2018). Dectin-1 stimulates IL-33 expression in dendritic cells via upregulation of IRF4. Laboratory Investigation. 98(6). 708–714. 8 indexed citations

17.

Chen, Jintong, Yinghua Zhao, Yuxue Jiang, et al.. (2018). Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells. Frontiers in Immunology. 9. 1787–1787. 41 indexed citations

18.

Zhu, Xiaoqing, Yinghua Zhao, Yuxue Jiang, et al.. (2017). Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1. Oncotarget. 8(32). 53366–53374. 17 indexed citations

19.

Chen, Jintong, Yinghua Zhao, Xiao Chu, et al.. (2016). Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy. OncoImmunology. 5(11). e1238558–e1238558. 12 indexed citations

20.

Zhao, Yinghua, Xiao Chu, Jintong Chen, et al.. (2016). Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nature Communications. 7(1). 12368–12368. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact